N-Acetylcysteine protects the peritoneum from the injury induced by hypertonic dialysis solution

被引:4
作者
Bui, Deborah S. S. [1 ]
Seguro, Antonio C. [1 ]
Shimitzu, Maria H. [1 ]
Schliemann, Igor [2 ]
Martini, Dino [2 ]
Romao, Joao E., Jr. [1 ]
Pecoits Filho, Roberto F. [3 ]
Abensur, Hugo [1 ]
机构
[1] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil
[2] Santa Casa de Misericordia Hosp Sao Paulo, Sao Paulo, Brazil
[3] Pontificia Univ Catolica Parana, Ctr Hlth & Biol Sci, Curitiba, Parana, Brazil
关键词
Acetylcysteine; Animal models; Oxidative stress; Peritoneal dialysis; OXIDATIVE STRESS; ADVANCED GLYCATION; RAT; PERMEABILITY; INFUSION; FLUID; MODEL;
D O I
10.5301/JN.2011.8404
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Oxidative stress has been implicated in the development of peritoneal damage. The aim of this study was to evaluate the effects of N-acetylcysteine (NAC) in a rat peritoneal infusion model. Methods: Eighteen male Wistar rats were divided in 3 groups: (i) control group; (ii) HDS group, receiving peritoneal dialysis solution (PDS); and (iii) HDS+NAC group, receiving PDS and oral NAC. Six weeks later they were evaluated for dialysate to plasma urea ratio (D/P), ratio of glucose concentration in peritoneal fluid (G1/G0), thiobarbituric acid reactive substances in plasma and urine and histology of peritoneal membrane. Results: The HDS+NAC group presented a lower increase in solute transport (D/P 0.51 +/- 0.1, and G1/GO 0.35 +/- 0.06) in comparison with the HDS group (D/P 0.67 +/- 0.1; p=0.03, and G1/G0 0.27 +/- 0.07; p=0.01). The HDS+NAC group showed lower thiobarbituric acid reactive substance concentrations compared with the HDS group. In the treated group, the peritoneal membrane presented lower thickness. Conclusions: Functional and histological peritoneal changes were significantly reduced by the treatment with NAC.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 21 条
[1]   Rat models in peritoneal dialysis [J].
Beelen, RHJ ;
Hekking, LHP ;
Zareie, M ;
van den Born, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (03) :672-674
[2]  
Bozkurt D, 2009, PERITON DIALYSIS INT, V29, pS202
[3]  
De Vriese AS, 2003, J AM SOC NEPHROL, V14, P2109, DOI 10.1681/ASN.V1482109
[4]   Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions [J].
Devuyst, O ;
Topley, N ;
Williams, JD .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 :12-15
[5]  
Günal AI, 2003, J NEPHROL, V16, P225
[6]   Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid [J].
Inagi, R ;
Miyata, T ;
Ueda, Y ;
Yoshino, A ;
Nangaku, M ;
de Strihou, CV ;
Kurokawa, K .
KIDNEY INTERNATIONAL, 2002, 62 (02) :679-687
[7]   Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats [J].
Kakuta, T ;
Tanaka, R ;
Satoh, Y ;
Izuhara, Y ;
Inagi, R ;
Nangaku, M ;
Saito, A ;
Miyata, T .
KIDNEY INTERNATIONAL, 2005, 68 (03) :1326-1336
[8]  
Krediet RT, 2000, PERITON DIAL INT S2, V20, P19
[9]  
Miyata T, 2000, J AM SOC NEPHROL, V11, P1744, DOI 10.1681/ASN.V1191744
[10]  
Nakayama M, 1999, PERITON DIALYSIS INT, V19, P207